Company Filing History:
Years Active: 2023
Title: Innovations in Genome Editing by Shuai Jin
Introduction
Shuai Jin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of genome editing, particularly through his innovative patent that enhances the specificity and stability of genetic modifications.
Latest Patents
Shuai Jin holds a patent titled "Method for genome editing using a self-inactivating CRISPR nuclease." This invention provides an improved genome editing system that is capable of obtaining stable mutation types with high specificity. The system includes an expression construct with a coding sequence of a gRNA targeting at least one genomic target sequence, an expression construct with a coding sequence of a CRISPR nuclease, and another expression construct with a coding sequence for a gRNA targeting a sequence within the coding sequence of the CRISPR nuclease. Upon introduction into the cell, the gRNA directs the CRISPR nuclease to the genomic target sequence, resulting in one or more mutations. Additionally, the gRNA targeting the CRISPR nuclease's coding sequence leads to an inactivating mutation of the CRISPR nuclease itself.
Career Highlights
Shuai Jin is affiliated with the Chinese Academy of Sciences, where he conducts his research and development in genome editing technologies. His work has garnered attention for its potential applications in various fields, including medicine and agriculture.
Collaborations
Shuai Jin collaborates with notable colleagues such as Caixia Gao and Huawei Zhang, contributing to advancements in genetic research and innovation.
Conclusion
Shuai Jin's contributions to genome editing through his innovative patent reflect his commitment to advancing scientific knowledge and technology. His work is poised to have a lasting impact on the field of genetics and beyond.